Drug intelligence / Profile preview

Welltone

Development stage
Unknown
Lead developer
SBM Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Welltone is a branded generic pharmaceutical formulation marketed by SBM Enterprises (SBM Pharmaceuticals), an Indian PCD (Propaganda Cum Distribution) company. It is typically formulated as a combination of methylcobalamin (Vitamin B12), alpha lipoic acid, pyridoxine (Vitamin B6), and folic acid, available in dosage forms such as capsules. Welltone functions as a neuroprotective agent and nutritional supplement, primarily indicated for the management of peripheral neuropathy, diabetic neuropathy, and various vitamin deficiencies. Methylcobalamin supports nerve myelination and regeneration, while alpha lipoic acid acts as a potent antioxidant that reduces oxidative stress in nerve tissues and improves microcirculation. Pyridoxine and folic acid serve as essential cofactors in metabolic processes, including the regulation of homocysteine levels, which is critical for cardiovascular and neurological health.

Brand names
Welltone
02

Targets

DLD (Dihydrolipoamide dehydrogenase)MTR (Methionine synthase)

Beyond the preview

Go deeper on Welltone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Welltone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call